{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T07:28:10Z","timestamp":1778311690905,"version":"3.51.4"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"7143","license":[{"start":{"date-parts":[[2007,5,23]],"date-time":"2007-05-23T00:00:00Z","timestamp":1179878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,5,23]],"date-time":"2007-05-23T00:00:00Z","timestamp":1179878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2007,5,24]]},"DOI":"10.1038\/nature05919","type":"journal-article","created":{"date-parts":[[2007,5,24]],"date-time":"2007-05-24T11:19:27Z","timestamp":1180005567000},"page":"433-440","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1347,"title":["Phenotypic plasticity and the epigenetics of human disease"],"prefix":"10.1038","volume":"447","author":[{"given":"Andrew P.","family":"Feinberg","sequence":"first","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2007,5,23]]},"reference":[{"key":"BFnature05919_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1749-6632.2002.tb04912.x","volume":"981","author":"L Van Speybroeck","year":"2002","unstructured":"Van Speybroeck, L. From epigenesis to epigenetics: the case of C. H. Waddington. Ann. NY Acad. Sci. 981, 61\u201381 (2002).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnature05919_CR2","first-page":"758","volume-title":"Inborn Errors of Development: The Molecular Basis of Clinical Disorders of Morphogenesis","author":"MR Debaun","year":"2004","unstructured":"Debaun, M. R. & Feinberg, A. P. in Inborn Errors of Development: The Molecular Basis of Clinical Disorders of Morphogenesis (ed. Epstein, C. J.) 758\u2013765 (Oxford Univ. Press, Oxford, USA, 2004)."},{"key":"BFnature05919_CR3","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1086\/425343","volume":"75","author":"EL Niemitz","year":"2004","unstructured":"Niemitz, E. L. et al. Microdeletion of LIT1 in familial Beckwith\u2013Wiedemann syndrome. Am. J. Hum. Genet. 75, 844\u2013849 (2004).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnature05919_CR4","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/ng1410","volume":"36","author":"A Sparago","year":"2004","unstructured":"Sparago, A. et al. Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith\u2013Wiedemann syndrome. Nature Genet. 36, 958\u2013960 (2004).","journal-title":"Nature Genet."},{"key":"BFnature05919_CR5","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1086\/338934","volume":"70","author":"MR DeBaun","year":"2002","unstructured":"DeBaun, M. R. et al. Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith\u2013Wiedemann syndrome with cancer and birth defects. Am. J. Hum. Genet. 70, 604\u2013611 (2002).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnature05919_CR6","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1136\/jmg.2004.030593","volume":"42","author":"N Diaz-Meyer","year":"2005","unstructured":"Diaz-Meyer, N., Yang, Y., Sait, S. N., Maher, E. R. & Higgins, M. J. Alternative mechanisms associated with silencing of CDKN1C in Beckwith\u2013Wiedemann syndrome. J. Med. Genet. 42, 648\u2013655 (2005).","journal-title":"J. Med. Genet."},{"key":"BFnature05919_CR7","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1159\/000090844","volume":"113","author":"B Horsthemke","year":"2006","unstructured":"Horsthemke, B. & Buiting, K. Imprinting defects on human chromosome 15. Cytogenet. Genome Res. 113, 292\u2013299 (2006).","journal-title":"Cytogenet. Genome Res."},{"key":"BFnature05919_CR8","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1172\/JCI12645","volume":"107","author":"M Lalande","year":"2001","unstructured":"Lalande, M. Imprints of disease at GNAS1. J. Clin. Invest. 107, 793\u2013794 (2001).","journal-title":"J. Clin. Invest."},{"key":"BFnature05919_CR9","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/13810","volume":"23","author":"RE Amir","year":"1999","unstructured":"Amir, R. E. et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature Genet. 23, 185\u2013188 (1999).","journal-title":"Nature Genet."},{"key":"BFnature05919_CR10","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrg1878","volume":"7","author":"T Bienvenu","year":"2006","unstructured":"Bienvenu, T. & Chelly, J. Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized. Nature Rev. Genet. 7, 415\u2013426 (2006).","journal-title":"Nature Rev. Genet."},{"key":"BFnature05919_CR11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/46052","volume":"402","author":"GL Xu","year":"1999","unstructured":"Xu, G. L. et al. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 402, 187\u2013191 (1999).","journal-title":"Nature"},{"key":"BFnature05919_CR12","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1182\/blood-2003-08-2632","volume":"103","author":"CE Blanco-Betancourt","year":"2004","unstructured":"Blanco-Betancourt, C. E. et al. Defective B-cell-negative selection and terminal differentiation in the ICF syndrome. Blood 103, 2683\u20132690 (2004).","journal-title":"Blood"},{"key":"BFnature05919_CR13","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/1096-8628(200023)97:3<204::AID-AJMG1038>3.0.CO;2-X","volume":"97","author":"RJ Gibbons","year":"2000","unstructured":"Gibbons, R. J. & Higgs, D. R. Molecular-clinical spectrum of the ATR-X syndrome. Am. J. Med. Genet. 97, 204\u2013212 (2000).","journal-title":"Am. J. Med. Genet."},{"key":"BFnature05919_CR14","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/376348a0","volume":"376","author":"F Petrif","year":"2002","unstructured":"Petrif, F. et al. Rubinstein\u2013Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 376, 348\u2013351 (2002).","journal-title":"Nature"},{"key":"BFnature05919_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/301089a0","volume":"301","author":"AP Feinberg","year":"1983","unstructured":"Feinberg, A. P. & Vogelstein, B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301, 89\u201392 (1983).","journal-title":"Nature"},{"key":"BFnature05919_CR16","first-page":"138","volume":"1775","author":"AS Wilson","year":"2007","unstructured":"Wilson, A. S., Power, B. E. & Molloy, P. L. DNA hypomethylation and human diseases. Biochim. Biophys. Acta 1775, 138\u2013162 (2007).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnature05919_CR17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrc1279","volume":"4","author":"AP Feinberg","year":"2004","unstructured":"Feinberg, A. P. & Tycko, B. The history of cancer epigenetics. Nature Rev. Cancer 4, 143\u2013153 (2004).","journal-title":"Nature Rev. Cancer"},{"key":"BFnature05919_CR18","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1158\/0008-5472.CAN-06-4074","volume":"67","author":"B Brueckner","year":"2007","unstructured":"Brueckner, B. et al. The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function. Cancer Res. 67, 1419\u20131423 (2007).","journal-title":"Cancer Res."},{"key":"BFnature05919_CR19","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/nature04225","volume":"438","author":"H Wu","year":"2005","unstructured":"Wu, H. et al. Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis. Nature 438, 981\u2013987 (2005).","journal-title":"Nature"},{"key":"BFnature05919_CR20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/BF00286709","volume":"83","author":"V Greger","year":"1989","unstructured":"Greger, V., Passarge, E., Hopping, W., Messmer, E. & Horsthemke, B. Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma. Hum. Genet. 83, 155\u2013158 (1989).","journal-title":"Hum. Genet."},{"key":"BFnature05919_CR21","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrg816","volume":"3","author":"PA Jones","year":"2002","unstructured":"Jones, P. A. & Baylin, S. B. The fundamental role of epigenetic events in cancer. Nature Rev. Genet. 3, 415\u2013428 (2002).","journal-title":"Nature Rev. Genet."},{"key":"BFnature05919_CR22","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/72785","volume":"24","author":"JF Costello","year":"2000","unstructured":"Costello, J. F. et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nature Genet. 24, 132\u2013138 (2000).","journal-title":"Nature Genet."},{"key":"BFnature05919_CR23","first-page":"3225","volume":"61","author":"M Esteller","year":"2001","unstructured":"Esteller, M., Corn, P. G., Baylin, S. B. & Herman, J. G. A gene hypermethylation profile of human cancer. Cancer Res. 61, 3225\u20133229 (2001).","journal-title":"Cancer Res."},{"key":"BFnature05919_CR24","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/ng1781","volume":"38","author":"J Frigola","year":"2006","unstructured":"Frigola, J. et al. Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band. Nature Genet. 38, 540\u2013549 (2006).","journal-title":"Nature Genet."},{"key":"BFnature05919_CR25","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1101\/gr.2431504","volume":"14","author":"N Hattori","year":"2004","unstructured":"Hattori, N. et al. Preference of DNA methyltransferases for CpG islands in mouse embryonic stem cells. Genome Res. 14, 1733\u20131740 (2004).","journal-title":"Genome Res."},{"key":"BFnature05919_CR26","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/ng1598","volume":"37","author":"M Weber","year":"2005","unstructured":"Weber, M. et al. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nature Genet. 37, 853\u2013862 (2005).","journal-title":"Nature Genet."},{"key":"BFnature05919_CR27","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ccr.2004.08.029","volume":"6","author":"D Gius","year":"2004","unstructured":"Gius, D. et al. Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach. Cancer Cell 6, 361\u2013371 (2004).","journal-title":"Cancer Cell"},{"key":"BFnature05919_CR28","doi-asserted-by":"publisher","first-page":"7480","DOI":"10.1073\/pnas.86.19.7480","volume":"86","author":"H Scrable","year":"1989","unstructured":"Scrable, H. et al. A model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting. Proc. Natl Acad. Sci. USA 86, 7480\u20137484 (1989).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature05919_CR29","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/362747a0","volume":"362","author":"S Rainier","year":"1993","unstructured":"Rainier, S. et al. Relaxation of imprinted genes in human cancer. Nature 362, 747\u2013749 (1993).","journal-title":"Nature"},{"key":"BFnature05919_CR30","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/362749a0","volume":"362","author":"O Ogawa","year":"1993","unstructured":"Ogawa, O. et al. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 362, 749\u2013751 (1993).","journal-title":"Nature"},{"key":"BFnature05919_CR31","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/ng0693-110","volume":"4","author":"AP Feinberg","year":"1993","unstructured":"Feinberg, A. P. Genomic imprinting and gene activation in cancer. Nature Genet. 4, 110\u2013113 (1993).","journal-title":"Nature Genet."},{"key":"BFnature05919_CR32","first-page":"1193","volume":"10","author":"M Kondo","year":"1995","unstructured":"Kondo, M. et al. Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers. Oncogene 10, 1193\u20131198 (1995).","journal-title":"Oncogene"},{"key":"BFnature05919_CR33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0014-5793(98)01211-3","volume":"437","author":"CE van Roozendaal","year":"1998","unstructured":"van Roozendaal, C. E. et al. Loss of imprinting of IGF2 and not H19 in breast cancer, adjacent normal tissue and derived fibroblast cultures. FEBS Lett. 437, 107\u2013111 (1998).","journal-title":"FEBS Lett."},{"key":"BFnature05919_CR34","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1158\/1541-7786.MCR-05-0138","volume":"4","author":"SK Murphy","year":"2006","unstructured":"Murphy, S. K. et al. Frequent IGF2\/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer. Mol. Cancer Res. 4, 283\u2013292 (2006).","journal-title":"Mol. Cancer Res."},{"key":"BFnature05919_CR35","first-page":"5356","volume":"56","author":"S Uyeno","year":"1996","unstructured":"Uyeno, S. et al. IGF2 but not H19 shows loss of imprinting in human glioma. Cancer Res. 56, 5356\u20135359 (1996).","journal-title":"Cancer Res."},{"key":"BFnature05919_CR36","first-page":"4174","volume":"63","author":"J Yuan","year":"2003","unstructured":"Yuan, J. et al. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers. Cancer Res 63, 4174\u20134180 (2003).","journal-title":"Cancer Res"},{"key":"BFnature05919_CR37","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/sj.bjc.6602478","volume":"92","author":"D Astuti","year":"2005","unstructured":"Astuti, D. et al. Epigenetic alteration at the DLK1\u2013GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour. Br. J. Cancer 92, 1574\u20131580 (2005).","journal-title":"Br. J. Cancer"},{"key":"BFnature05919_CR38","first-page":"5449","volume":"59","author":"IS Pedersen","year":"1999","unstructured":"Pedersen, I. S. et al. Frequent loss of imprinting of PEG1\/MEST in invasive breast cancer. Cancer Res 59, 5449\u20135451 (1999).","journal-title":"Cancer Res"},{"key":"BFnature05919_CR39","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/nature01075","volume":"419","author":"S Varambally","year":"2002","unstructured":"Varambally, S., et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419, 624\u2013629 (2002).","journal-title":"Nature"},{"key":"BFnature05919_CR40","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/ng1531","volume":"37","author":"MF Fraga","year":"2005","unstructured":"Fraga, M. F. et al. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nature Genet. 37, 391\u2013400 (2005).","journal-title":"Nature Genet."},{"key":"BFnature05919_CR41","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/35104508","volume":"414","author":"H Tamaru","year":"2001","unstructured":"Tamaru, H. & Selker, E. U. A histone H3 methyltransferase controls DNA methylation in Neurospora crassa. Nature 414, 277\u2013283 (2001).","journal-title":"Nature"},{"key":"BFnature05919_CR42","doi-asserted-by":"publisher","first-page":"6629","DOI":"10.1073\/pnas.0507425103","volume":"103","author":"R Terranova","year":"2006","unstructured":"Terranova, R., Agherbi, H., Boned, A., Meresse, S. & Djabali, M. Histone and DNA methylation defects at Hox genes in mice expressing a SET domain-truncated form of Mll. Proc. Natl Acad. Sci. USA 103, 6629\u20136634 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature05919_CR43","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1101\/gad.1463706","volume":"20","author":"PO Esteve","year":"2006","unstructured":"Esteve, P. O. et al. Direct interaction between DNMT1and G9a coordinates DNA and histone methylation during replication. Genes Dev. 20, 3089\u20133103 (2006).","journal-title":"Genes Dev."},{"key":"BFnature05919_CR44","doi-asserted-by":"publisher","first-page":"4152","DOI":"10.1073\/pnas.95.8.4152","volume":"95","author":"O Rozenblatt-Rosen","year":"1998","unstructured":"Rozenblatt-Rosen, O. et al. The C-terminal SET domains of ALL-1 and TRITHORAX interact with the INI1 and SNR1 proteins, components of the SWI\/SNF complex. Proc. Natl Acad. Sci. USA 95, 4152\u20134157 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature05919_CR45","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/28212","volume":"394","author":"I Versteege","year":"1998","unstructured":"Versteege, I. et al. Truncating mutations of hSNF5\/INI1 in aggressive paediatric cancer. Nature 394, 203\u2013206 (1998).","journal-title":"Nature"},{"key":"BFnature05919_CR46","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/ng863","volume":"30","author":"N Kurotaki","year":"2002","unstructured":"Kurotaki, N. et al. Haploinsufficiency of NSD1 causes Sotos syndrome. Nature Genet. 30, 365\u2013366 (2002).","journal-title":"Nature Genet."},{"key":"BFnature05919_CR47","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/0092-8674(83)90388-4","volume":"34","author":"MR Scott","year":"1983","unstructured":"Scott, M. R., Westphal, K. H. & Rigby, P. W. Activation of mouse genes in transformed cells. Cell 34, 557\u2013567 (1983).","journal-title":"Cell"},{"key":"BFnature05919_CR48","doi-asserted-by":"publisher","first-page":"8698","DOI":"10.1073\/pnas.95.15.8698","volume":"95","author":"ML Veigl","year":"1998","unstructured":"Veigl, M. L. et al. Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc. Natl Acad. Sci. USA 95, 8698\u20138702 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature05919_CR49","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S1535-6108(02)00234-9","volume":"3","author":"KE Bachman","year":"2003","unstructured":"Bachman, K. E. et al. Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. Cancer Cell 3, 89\u201395 (2003).","journal-title":"Cancer Cell"},{"key":"BFnature05919_CR50","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/S0022-3476(98)70008-3","volume":"132","author":"MR DeBaun","year":"1998","unstructured":"DeBaun, M. R. & Tucker, M. A. Risk of cancer during the first four years of life in children from the Beckwith\u2013Wiedemann syndrome registry. J. Pediatr. 132, 398\u2013400 (1998).","journal-title":"J. Pediatr."},{"key":"BFnature05919_CR51","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/3260","volume":"4","author":"H Cui","year":"1998","unstructured":"Cui, H., Horon, I. L., Ohlsson, R., Hamilton, S. R. & Feinberg, A. P. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nature Med. 4, 1276\u20131280 (1998).","journal-title":"Nature Med."},{"key":"BFnature05919_CR52","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1126\/science.1080902","volume":"299","author":"H Cui","year":"2003","unstructured":"Cui, H. et al. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 299, 1753\u20131755 (2003).","journal-title":"Science"},{"key":"BFnature05919_CR53","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/jnci\/djh042","volume":"96","author":"K Woodson","year":"2004","unstructured":"Woodson, K. et al. Loss of insulin-like growth factor-II imprinting and the presence of screen-detected colorectal adenomas in women. J. Natl Cancer Inst. 96, 407\u2013410 (2004).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnature05919_CR54","doi-asserted-by":"publisher","first-page":"8681","DOI":"10.1073\/pnas.96.15.8681","volume":"96","author":"M Toyota","year":"1999","unstructured":"Toyota, M. et al. CpG island methylator phenotype in colorectal cancer. Proc. Natl Acad. Sci. USA 96, 8681\u20138686 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature05919_CR55","first-page":"1596","volume":"63","author":"CR Holst","year":"2003","unstructured":"Holst, C. R. et al. Methylation of p16INK4a promoters occurs in vivo in histologically normal human mammary epithelia. Cancer Res. 63, 1596\u20131601 (2003).","journal-title":"Cancer Res."},{"key":"BFnature05919_CR56","doi-asserted-by":"publisher","first-page":"13580","DOI":"10.1073\/pnas.0506612102","volume":"102","author":"Y Yamada","year":"2005","unstructured":"Yamada, Y. et al. Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. Proc. Natl Acad. Sci. USA 102, 13580\u201313585 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature05919_CR57","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1126\/science.1083558","volume":"300","author":"F Gaudet","year":"2003","unstructured":"Gaudet, F. et al. Induction of tumors in mice by genomic hypomethylation. Science 300, 489\u2013492 (2003).","journal-title":"Science"},{"key":"BFnature05919_CR58","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1126\/science.1083557","volume":"300","author":"A Eden","year":"2003","unstructured":"Eden, A., Gaudet, F., Waghmare, A. & Jaenisch, R. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 300, 455 (2003).","journal-title":"Science"},{"key":"BFnature05919_CR59","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0092-8674(95)90329-1","volume":"81","author":"PW Laird","year":"1995","unstructured":"Laird, P. W. et al. Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81, 197\u2013205 (1995).","journal-title":"Cell"},{"key":"BFnature05919_CR60","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/ng1077","volume":"33","author":"WY Chen","year":"2003","unstructured":"Chen, W. Y. et al. Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors. Nature Genet. 33, 197\u2013202 (2003).","journal-title":"Nature Genet."},{"key":"BFnature05919_CR61","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1126\/science.1108080","volume":"307","author":"T Sakatani","year":"2005","unstructured":"Sakatani, T. et al. Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice. Science 307, 1976\u20131978 (2005).","journal-title":"Science"},{"key":"BFnature05919_CR62","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ccr.2005.09.007","volume":"8","author":"TM Holm","year":"2005","unstructured":"Holm, T. M. et al. Global loss of imprinting leads to widespread tumorigenesis in adult mice. Cancer Cell 8, 275\u2013285 (2005).","journal-title":"Cancer Cell"},{"key":"BFnature05919_CR63","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nrg1748","volume":"7","author":"AP Feinberg","year":"2006","unstructured":"Feinberg, A. P., Ohlsson, R. & Henikoff, S. The epigenetic progenitor origin of human cancer. Nature Rev. Genet. 7, 21\u201333 (2006).","journal-title":"Nature Rev. Genet."},{"key":"BFnature05919_CR64","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1158\/0008-5472.CAN-05-2036","volume":"66","author":"J Harper","year":"2006","unstructured":"Harper, J. et al. Soluble IGF2 receptor rescues ApcMin\/+ intestinal adenoma progression induced by Igf2 loss of imprinting. Cancer Res. 66, 1940\u20131948 (2006).","journal-title":"Cancer Res."},{"key":"BFnature05919_CR65","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1093\/jnci\/93.22.1698","volume":"93","author":"JD Ravenel","year":"2001","unstructured":"Ravenel, J.D. et al. Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor. J. Natl Cancer Inst. 93, 1698\u20131703 (2001).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnature05919_CR66","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1101\/gad.1213504","volume":"18","author":"K Hochedlinger","year":"2004","unstructured":"Hochedlinger, K. et al. Reprogramming of a melanoma genome by nuclear transplantation. Genes Dev. 18, 1875\u20131885 (2004).","journal-title":"Genes Dev."},{"key":"BFnature05919_CR67","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/ng1596","volume":"37","author":"M Hu","year":"2005","unstructured":"Hu, M. et al. Distinct epigenetic changes in the stromal cells of breast cancers. Nature Genet. 37, 899\u2013905 (2005).","journal-title":"Nature Genet."},{"key":"BFnature05919_CR68","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.cell.2006.02.041","volume":"125","author":"BE Bernstein","year":"2006","unstructured":"Bernstein, B. E. et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125, 315\u2013326 (2006).","journal-title":"Cell"},{"key":"BFnature05919_CR69","doi-asserted-by":"publisher","first-page":"9245","DOI":"10.1158\/0008-5472.CAN-05-1691","volume":"65","author":"SJ Horton","year":"2005","unstructured":"Horton, S. J. et al. Continuous MLL\u2013ENL expression is necessary to establish a 'Hox Code' and maintain immortalization of hematopoietic progenitor cells. Cancer Res. 65, 9245\u20139252 (2005).","journal-title":"Cancer Res."},{"key":"BFnature05919_CR70","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/nature04980","volume":"442","author":"AV Krivtsov","year":"2006","unstructured":"Krivtsov, A. V. et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 442, 818\u2013822 (2006).","journal-title":"Nature"},{"key":"BFnature05919_CR71","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nature04733","volume":"441","author":"LA Boyer","year":"2006","unstructured":"Boyer, L. A. et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441, 349\u2013353 (2006).","journal-title":"Nature"},{"key":"BFnature05919_CR72","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/42706","volume":"387","author":"DH Skuse","year":"1997","unstructured":"Skuse, D. H. et al. Evidence from Turner's syndrome of an imprinted X-linked locus affecting cognitive function. Nature 387, 705\u2013708 (1997).","journal-title":"Nature"},{"key":"BFnature05919_CR73","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/ng1567","volume":"37","author":"AS Raefski","year":"2005","unstructured":"Raefski, A. S. & O'Neill, M. J. Identification of a cluster of X-linked imprinted genes in mice. Nature Genet. 37, 620\u2013624 (2005).","journal-title":"Nature Genet."},{"key":"BFnature05919_CR74","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1017\/S0033291700028099","volume":"25","author":"A Bailey","year":"1995","unstructured":"Bailey, A. et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol. Med. 25, 63\u201377 (1995).","journal-title":"Psychol. Med."},{"key":"BFnature05919_CR75","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1176\/appi.ajp.161.3.539","volume":"161","author":"WR Kates","year":"2004","unstructured":"Kates, W. R. et al. Neuroanatomic variation in monozygotic twin pairs discordant for the narrow phenotype for autism. Am. J. Psychiatry 161, 539\u2013546 (2004).","journal-title":"Am. J. Psychiatry"},{"key":"BFnature05919_CR76","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/sj.mp.4001662","volume":"10","author":"T Kato","year":"2005","unstructured":"Kato, T., Iwamoto, K., Kakiuchi, C., Kuratomi, G. & Okazaki, Y. Genetic or epigenetic difference causing discordance between monozygotic twins as a clue to molecular basis of mental disorders. Mol. Psychiatry 10, 622\u2013630 (2005).","journal-title":"Mol. Psychiatry"},{"key":"BFnature05919_CR77","doi-asserted-by":"crossref","unstructured":"International Molecular Genetic Study of Autism Consortium. Further characterization of the autism susceptibility locus AUTS1 on chromosome 7q. Hum. Mol. Genet. 10, 973\u2013982 (2001).","DOI":"10.1093\/hmg\/10.9.973"},{"key":"BFnature05919_CR78","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/sj.mp.4001277","volume":"8","author":"MG McInnis","year":"2003","unstructured":"McInnis, M. G. et al. Genome-wide scan of bipolar disorder in 65 pedigrees: supportive evidence for linkage at 8q24, 18q22, 4q32, 2p12, and 13q12. Mol. Psychiatry 8, 288\u2013298 (2003).","journal-title":"Mol. Psychiatry"},{"key":"BFnature05919_CR79","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.arr.2006.07.001","volume":"5","author":"Q Lu","year":"2006","unstructured":"Lu, Q. et al. Epigenetics, disease, and therapeutic interventions. Ageing Res. Rev. 5, 449\u2013467 (2006).","journal-title":"Ageing Res. Rev."},{"key":"BFnature05919_CR80","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1172\/JCI116576","volume":"92","author":"J Quddus","year":"1993","unstructured":"Quddus, J. et al. Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J. Clin. Invest. 92, 38\u201353 (1993).","journal-title":"J. Clin. Invest."},{"key":"BFnature05919_CR81","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S1521-6616(03)00206-7","volume":"109","author":"B Richardson","year":"2003","unstructured":"Richardson, B. DNA methylation and autoimmune disease. Clin. Immunol. 109, 72\u201379 (2003).","journal-title":"Clin. Immunol."},{"key":"BFnature05919_CR82","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1749-6632.2003.tb05970.x","volume":"983","author":"JE Sutherland","year":"2003","unstructured":"Sutherland, J. E. & Costa, M. Epigenetics and the environment. Ann. NY Acad. Sci. 983, 151\u2013160 (2003).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnature05919_CR83","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1126\/science.1108190","volume":"308","author":"MD Anway","year":"2005","unstructured":"Anway, M. D., Cupp, A. S., Uzumcu, M. & Skinner, M. K. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 308, 1466\u20131469 (2005).","journal-title":"Science"},{"key":"BFnature05919_CR84","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1093\/hmg\/ddi484","volume":"15","author":"RA Waterland","year":"2006","unstructured":"Waterland, R. A., Lin, J. R., Smith, C. A. & Jirtle, R. L. Post-weaning diet affects genomic imprinting at the insulin-like growth factor 2 (Igf2) locus. Hum. Mol. Genet. 15, 705\u2013716 (2006).","journal-title":"Hum. Mol. Genet."},{"key":"BFnature05919_CR85","doi-asserted-by":"publisher","first-page":"5293","DOI":"10.1128\/MCB.23.15.5293-5300.2003","volume":"23","author":"RA Waterland","year":"2003","unstructured":"Waterland, R. A. & Jirtle, R. L. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol. Cell. Biol. 23, 5293\u20135300 (2003).","journal-title":"Mol. Cell. Biol."},{"key":"BFnature05919_CR86","doi-asserted-by":"publisher","first-page":"2475S","DOI":"10.1093\/jn\/134.9.2475S","volume":"134","author":"E Giovannucci","year":"2004","unstructured":"Giovannucci, E. Alcohol, one-carbon metabolism, and colorectal cancer: recent insights from molecular studies. J. Nutr. 134, 2475S\u20132481S (2004).","journal-title":"J. Nutr."},{"key":"BFnature05919_CR87","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nn1276","volume":"7","author":"IC Weaver","year":"2004","unstructured":"Weaver, I. C. et al. Epigenetic programming by maternal behavior. Nature Neurosci. 7, 847\u2013854 (2004).","journal-title":"Nature Neurosci."},{"key":"BFnature05919_CR88","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1086\/346031","volume":"72","author":"MR DeBaun","year":"2003","unstructured":"DeBaun, M. R., Niemitz, E. L. & Feinberg, A. P. Association of in vitro fertilization with Beckwith\u2013Wiedemann syndrome and epigenetic alterations of LIT1 and H19. Am. J. Hum. Genet. 72, 156\u2013160 (2003).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnature05919_CR89","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1086\/382897","volume":"74","author":"EL Niemitz","year":"2004","unstructured":"Niemitz, E. L. & Feinberg, A. P. Epigenetics and assisted reproductive technology: a call for investigation. Am. J. Hum. Genet. 74, 599\u2013609 (2004).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnature05919_CR90","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.tig.2004.06.009","volume":"20","author":"HT Bjornsson","year":"2004","unstructured":"Bjornsson, H. T., Fallin, M. D. & Feinberg, A. P. An integrated epigenetic and genetic approach to common human disease. Trends Genet. 20, 350\u2013358 (2004).","journal-title":"Trends Genet."},{"key":"BFnature05919_CR91","doi-asserted-by":"publisher","first-page":"10604","DOI":"10.1073\/pnas.0500398102","volume":"102","author":"MF Fraga","year":"2005","unstructured":"Fraga, M. F. et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl Acad. Sci. USA 102, 10604\u201310609 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature05919_CR92","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/24550","volume":"396","author":"SL Rutherford","year":"1998","unstructured":"Rutherford, S. L. & Lindquist, S. Hsp90 as a capacitor for morphological evolution. Nature 396, 336\u2013342 (1998).","journal-title":"Nature"},{"key":"BFnature05919_CR93","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/ng1067","volume":"33","author":"V Sollars","year":"2003","unstructured":"Sollars, V. et al. Evidence for an epigenetic mechanism by which Hsp90 acts as a capacitor for morphological evolution. Nature Genet. 33, 70\u201374 (2003).","journal-title":"Nature Genet."},{"key":"BFnature05919_CR94","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/ng1844","volume":"38","author":"B Lehner","year":"2006","unstructured":"Lehner, B., Crombie, C., Tischler, J., Fortunato, A. & Fraser, A. G. Systematic mapping of genetic interactions in Caenorhabditis elegans identifies common modifiers of diverse signaling pathways. Nature Genet. 38, 896\u2013903 (2006).","journal-title":"Nature Genet."},{"key":"BFnature05919_CR95","doi-asserted-by":"publisher","first-page":"R95","DOI":"10.1093\/hmg\/ddl095","volume":"15","author":"PA Callinan","year":"2006","unstructured":"Callinan, P. A. & Feinberg, A. P. The emerging science of epigenomics. Hum. Mol. Genet. 15, R95\u2013R101 (2006).","journal-title":"Hum. Mol. Genet."},{"key":"BFnature05919_CR96","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1093\/jnci\/djj447","volume":"98","author":"GS Mack","year":"2006","unstructured":"Mack, G. S. Epigenetic cancer therapy makes headway. J. Natl Cancer Inst. 98, 1443\u20131444 (2006).","journal-title":"J. Natl Cancer Inst."},{"issue":"suppl. 13","key":"BFnature05919_CR97","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s00277-005-0019-7","volume":"84","author":"KW Yee","year":"2005","unstructured":"Yee, K. W., Jabbour, E., Kantarjian, H. M. & Giles, F. J. Clinical experience with decitabine in North American patients with myelodysplastic syndrome. Ann. Hematol. 84 (suppl. 13), 18\u201324 (2005).","journal-title":"Ann. Hematol."},{"key":"BFnature05919_CR98","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/S0076-6879(03)76012-1","volume":"376","author":"Y Zheng","year":"2004","unstructured":"Zheng, Y. et al. Selective HAT inhibitors as mechanistic tools for protein acetylation. Methods Enzymol. 376, 188\u2013199 (2004).","journal-title":"Methods Enzymol."},{"key":"BFnature05919_CR99","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1038\/sj.onc.1207118","volume":"23","author":"NG Iyer","year":"2004","unstructured":"Iyer, N. G., Ozdag, H. & Caldas, C. p300\/CBP and cancer. Oncogene 23, 4225\u20134231 (2004).","journal-title":"Oncogene"},{"key":"BFnature05919_CR100","doi-asserted-by":"publisher","first-page":"36734","DOI":"10.1074\/jbc.M101287200","volume":"276","author":"CJ Phiel","year":"2001","unstructured":"Phiel, C. J. et al. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J. Biol. Chem. 276, 36734\u201336741 (2001).","journal-title":"J. Biol. Chem."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nature05919.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nature05919","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nature05919.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T17:12:40Z","timestamp":1650388360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature05919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,23]]},"references-count":100,"journal-issue":{"issue":"7143","published-print":{"date-parts":[[2007,5,24]]}},"alternative-id":["BFnature05919"],"URL":"https:\/\/doi.org\/10.1038\/nature05919","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,23]]},"assertion":[{"value":"23 May 2007","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}